CoChat

Methylation of IL‐2 promoter at birth alters the risk of asthma exacerbations during childhood

Open access
Curtin, J. A., Simpson, A., Belgrave, D., Semic‐Jusufagic, A., Custovic, A., Martinez, F. D. · 2013 · Clinical & Experimental Allergy
Cited by 41

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Background: Epigenetic modifications may have a role in asthma susceptibility. Objective: To investigate whether epigenetic modification at birth of a CpG site necessary for the regulation of IL‐2 transcription (IL‐2 Site1) is associated with the development of asthma during childhood. Methods: Methylation of IL‐2 Site1 was assessed in cord blood from 303 children (225 with atopic mothers); as controls, we measured methylation of a site not important in the transcription of IL‐2 (IL‐2 Site7) and methylation of the LINE‐1 repetitive element. Children were followed to the age of 8 years. Information on severe asthma exacerbations and hospital admissions was collected from child's primary care medical record. To account for potential confounding by bronchiolitis, we used exacerbations/hospitalizations after age 1 year as primary outcomes. Results: There were 49 severe exacerbations amongst 33 children, and 22 hospital admissions amongst 11 children. The risk of asthma exacerbation increased 1.07‐fold (95% CI 1.01–1.14, P = 0.03) and the risk of hospital admission increased 1.12‐fold (95% CI 1.04–1.20, P = 0.002) for each one per cent increase in IL‐2 Site1 methylation. Children who were admitted to hospital at any time‐point had significantly higher IL‐2 Site1 methylation than children not admitted to hospital (P = 0.007). There was a significant interaction between age at exacerbation (P = 0.03) or hospital admission (P = 0.02) and methylation, with the effect of methylation increasing with increasing age. Methylation of the control IL‐2 Site7 or LINE‐1 was not a significant predictor of asthma exacerbations/hospital admission, and we found no association between IL‐2 Site1 methylation and hospital admissions for other reasons (0.99 [0.92–1.06]). Cord blood mononuclear cell phytohemagglutinin‐stimulated lymphoproliferative responses decreased significantly with increasing IL‐2 Site1 methylation (P < 0.001). Conclusions: Increasing methylation in cord blood of a functional CpG site in the IL‐2 promoter is associated with increased likelihood of severe asthma exacerbations and hospital admissions for asthma/wheeze between ages of 2 and 8 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cea.12046

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Curtin, J. A., Simpson, A., Belgrave, D., Semic‐Jusufagic, A., Custovic, A., & Martinez, F. D.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2013-02-17
Volume
43
Issue
3
Pages
304-311
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2010901458
Cited by
41
References
6
FWCI
2.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.